The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges. Peng GY, Lin Y, Li JJ, Wang Y, Huang HY, Shen ZY. Stem Cells Int. 2019 Jun 12;2019:9613258.1.
Toward In Vivo Gene Therapy Using CRISPR. Skipper KA, Mikkelsen JG. Methods Mol Biol. 2019;1961:293-306.
Translatable gene therapy for lung cancer using Crispr CAS9-an exploratory review. Nair J, Nair A, Veerappan S, Sen D. Cancer Gene Ther. 2019 Jun 20. doi: 10.1038/s41417-019-0116-8.
Advances in the techniques and methodologies of cancer gene therapy. Sun W, Shi Q, Zhang H, Yang K, Ke Y, Wang Y, Qiao L. Discov Med. 2019 Jan;27(146):45-55.
Gene Therapy Tools for Brain Diseases. Ingusci S, Verlengia G, Soukupova M, Zucchini S, Simonato M. Front Pharmacol. 2019 Jul 1;10:724.
Delivery systems of CRISPR/Cas9-based cancer gene therapy. Biagioni A, Laurenzana A, Margheri F, Chillà A, Fibbi G, Del Rosso M. J Biol Eng. 2018 Dec 18;12:33.
Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. Hernández R, Sánchez-Jiménez E, Melguizo C, Prados J, Rama AR. BMB Rep. 2018 Nov;51(11):563-571
Nonviral Gene Therapy for Cancer. Hidai C, Kitano H. Diseases. 2018 Jul 3;6(3).
Nonviral Delivery Systems for Cancer Gene Therapy: Strategies and Challenges. Shim G, Kim D, Le QV, Park GT, Kwon T, Oh YK. Curr Gene Ther. 2018;18(1):3-20
Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer. Marofi F, Vahedi G, Biglari A, Esmaeilzadeh A, Athari SS. Front Immunol. 2017 Dec 18;8:1770.
Nanoparticles for death‑induced gene therapy in cancer . Roacho-Perez JA, Gallardo-Blanco HL, Sanchez-Dominguez M, Garcia-Casillas PE, Chapa-Gonzalez C, Sanchez-Dominguez CN. Mol Med Rep. 2018 Jan;17(1):1413-1420
Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence. Clément F, Grockowiak E, Zylbersztejn F, Fossard G, Gobert S, Maguer-Satta V. Stem Cell Investig. 2017 Jul 25;4:67.
Nanovesicular Formulations for Cancer Gene Therapy. Tavano L, Mazzotta E, Muzzalupo R. Curr Pharm Des. 2017;23(35):5327-5335
Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review. Yousefpour Marzbali M, Yari Khosroushahi A. Cancer Chemother Pharmacol. 2017 Apr;79(4):637-649.
Enzyme/Prodrug Systems for Cancer Gene Therapy. Malekshah OM, Chen X, Nomani A, Sarkar S, Hatefi A. Curr Pharmacol Rep. 2016 Dec;2(6):299-308
Mesenchymal stem cell: a new horizon in cancer gene therapy. Mohammadi M, Jaafari MR, Mirzaei HR, Mirzaei H. Cancer Gene Ther. 2016 Sep;23(9):285-6.
CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer. Sachdeva M, Sachdeva N, Pal M, Gupta N, Khan IA, Majumdar M, Tiwari A. Cancer Gene Ther. 2015 Nov;22(11):509-17
Strategies used in the clinical trials of gene therapy for cancer. Ajith TA. J Exp Ther Oncol. 2015;11(1):33-9
Tissue Specific Promoters in Colorectal Cancer. Rama AR, Aguilera A, Melguizo C, Caba O, Prados J. Dis Markers. 2015;2015:390161.
How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment. Prados J1, Alvarez PJ, Melguizo C, Rodriguez-Serrano F, Carrillo E, Boulaiz H, Vélez C, Marchal JA, Caba O, Ortiz R, Rama A, Aranega A. Curr Med Chem. 2012;19(12):1870-88.
Translating Regenerative Medicine to the Clinic. Jeffrey Laurence (Eds). Elsevier B.V. 2019.
Second-Generation Cell and Gene-Based Therapies. 1st Edition Biological Advances, Clinical Outcomes, and Strategies for Capitalization. Alain Vertes Nathan Dowden Devyn Smith Nasib Qureshi (Eds). Elsevier. 2019
A Guide to Human Gene Therapy. Roland W. Herzog (Author, Editor). World Scientific Publishing Company. 2010
Cancer gene therapy. Strategies and clinical trials. J. Prados, C. Melguizo, H. Boulaiz, J.A. Marchal, A. Aránega. Cell. Mol. Biol., 51: 23-26, 2005
